Daiwa Securities Group
TXG icon

Daiwa Securities Group’s 10x Genomics TXG Stock Holding History

Daiwa Securities Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-370
Closed -$6K – 1432
2025
Q4 		$6K Hold
370
– – ﹤0.01% 1227
2025
Q3 		$4K Hold
370
– – ﹤0.01% 1228
2025
Q2 		$4K Hold
370
– – ﹤0.01% 1179
2025
Q1 		$3K Buy
+370
New +$4.66K ﹤0.01% 1169
2022
Q2 		– Sell
-3,768
Closed -$287K – 1427
2022
Q1 		$287K Hold
3,768
– – ﹤0.01% 940
2021
Q4 		$561K Sell
3,768
-1,570
-29% -$240K ﹤0.01% 844
2021
Q3 		$777K Buy
5,338
+46
+0.9% +$7.9K 0.01% 739
2021
Q2 		$1.04M Buy
5,292
+2,374
+81% +$430K 0.01% 628
2021
Q1 		$528K Buy
2,918
+397
+16% +$68.6K ﹤0.01% 790
2020
Q4 		$357K Buy
+2,521
New +$366K ﹤0.01% 829

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's TXG Position: Q1 2026 in Review

Daiwa Securities Group sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 370 shares — an estimated $6K sold.

Daiwa Securities Group first reported a position in TXG in Q4 2020 and held it in 10 quarters. The position peaked at $1.04M in Q2 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Daiwa Securities Group reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 370 10x Genomics shares in Q1 2026, an estimated $6K.
  • Daiwa Securities Group first reported a position in 10x Genomics in Q4 2020 and held it in 10 quarters.
  • Daiwa Securities Group's 10x Genomics position peaked at $1.04M in Q2 2021.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.